The Egyptian Drug Authority announces the publication of the fourth edition of the Regulatory Guide on the Registration of Synthetic Peptides Human Pharmaceutical Products that refer to a Reference Peptide Product of rDNA Origin.

This comes as part of the Egyptian Drug Authority’s commitment to keeping pace with the latest developments in international standards, and its ongoing efforts to support pharmaceutical companies, promote investment in the pharmaceutical industry, and facilitate drug registration procedures.

to view the guideline press the link